Piperidine → HCID 178518474, 화합물
반응식
[O:1]1[CH2:6][CH2:5][N:4]([CH2:7][CH2:8][O:9][C:10]2[CH:11]=[C:12]([NH:16][C:17]3[CH:22]=[CH:21][N:20]4[N:23]=[CH:24][C:25]([CH:26]=O)=[C:19]4[N:18]=3)[CH:13]=[CH:14][CH:15]=2)[CH2:3][CH2:2]1.[NH:28]1[CH2:34][C:32](=[O:33])[NH:31][C:29]1=[O:30].N1CCCCC1>CCO>[O:1]1[CH2:6][CH2:5][N:4]([CH2:7][CH2:8][O:9][C:10]2[CH:11]=[C:12]([NH:16][C:17]3[CH:22]=[CH:21][N:20]4[N:23]=[CH:24][C:25]([CH:26]=[C:34]5[NH:28][C:29](=[O:30])[NH:31][C:32]5=[O:33])=[C:19]4[N:18]=3)[CH:13]=[CH:14][CH:15]=2)[CH2:3][CH2:2]1참가 물질
5
반응 조건
- 온도
- 70 °C
실험 절차
To 5-(3-(2-morpholinoethoxy)phenylamino)pyrazolo[1,5-a]pyrimidine-3-carbaldehyde (81 mg, 0.221 mmol) in EtOH was added hydantoin (27 mg, 0.270 mmol) and piperidine (22 μL, 0.221 mmol). The mixture was heated at 70° C. for 48 hr. The solution was then purified by HPLC to yield 5-((5-(3-(2-morpholinoethoxy)phenylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methylene)imidazolidine-2,4-dione. LCMS (M+1=450)
후처리
- customThe solution was then purified by HPLC
출처 및 근거
- ORD 기록
- ord-3d595355233d4effb555f46cb6b57787
- 출처 데이터셋
- uspto-grants-2013_02
- 특허 번호
- US08367681B2
반응 노트
불러오는 중…